Kritchavat Ploddi

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 4

Top Topics

Coronavirus Disease

Cross Sectional

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Natthaprang Nittayasoot, Rapeepong Suphanchaimat, Panithee Thammawijaya, Chuleeporn Jiraphongsa, Taweesap Siraprapasiri, Kritchavat Ploddi, Chakkarat Pittayawonganon, Surakameth Mahasirimongkol, Piyanit Tharmaphornpilas
Real-World Effectiveness of COVID-19 Vaccines against Severe Outcomes during the Period of Omicron Predominance in Thailand: A Test-Negative Nationwide Case-Control Study. Vaccines 10 (12) (2022)
Natthaprang Nittayasoot, Rapeepong Suphanchaimat, Panithee Thammawijaya, Chuleeporn Jiraphongsa, Taweesap Siraprapasiri, Kritchavat Ploddi, Chakkarat Pittayawonganon, Surakameth Mahasirimongkol, Piyanit Tharmaphornpilas
Real-World Effectiveness of COVID-19 Vaccines against Severe Outcomes during the Period of Omicron Predominance in Thailand: A Test-Negative Nationwide Case-Control Study. Vaccines 10 (12) (2022)
Natthaprang Nittayasoot, Rapeepong Suphanchaimat, Panithee Thammawijaya, Chuleeporn Jiraphongsa, Taweesap Siraprapasiri, Kritchavat Ploddi, Chakkarat Pittayawonganon, Surakameth Mahasirimongkol, Piyanit Tharmaphornpilas
Real-World Effectiveness of COVID-19 Vaccines against Severe Outcomes during the Period of Omicron Predominance in Thailand: A Test-Negative Nationwide Case-Control Study. Vaccines 10 (12) (2022)
Natthaprang Nittayasoot, Rapeepong Suphanchaimat, Panithee Thammawijaya, Chuleeporn Jiraphongsa, Taweesap Siraprapasiri, Kritchavat Ploddi, Chakkarat Pittayawonganon, Surakameth Mahasirimongkol, Piyanit Tharmaphornpilas
Real-World Effectiveness of COVID-19 Vaccines against Severe Outcomes during the Period of Omicron Predominance in Thailand: A Test-Negative Nationwide Case-Control Study. Vaccines 10 (12) (2022)